The company signed distribution agreements covering 15 countries for its PlexWell technology and products for multiplexed NGS applications.
The firm's technology can perform in-droplet centrifugation, 10-second cell lysis, and sound wave-based PCR on the surface of an inexpensive polymer chip.
SeqOnce, which was founded in 2014, has developed a technology for NGS library preparation that it says is significantly quicker than competing methods.
The team evaluated BSTs from Norgen, Streck, Roche Diagnostics and PreAnalytix, and said Norgen's was the best in terms of genetic material storage.
The new grant from Innovate UK will fund development of a sample preparation system to support POC infectious disease pathogen detection.
Twist continues to invest in NGS while growing its core synthetic biology business, and has filed a countercomplaint in its ongoing litigation with Agilent.
The firm recognized revenues in fiscal Q1 2019 of $11.5 million, driven by rapid growth in its NGS products as well as its synthetic biology business.
Alliance Global will distribute Mawi's iSWAB biosampling technologies to the Middle East, Africa, and parts of Central and South Asia.
The device can process high-volume sputum samples for PCR-based Mycobacterium tuberculosis detection at smear-negative, culture-positive levels.
The companies will join certain of their respective technologies into a single product for low-pass whole-genome sequencing and genotype imputation.
The Boston-based startup will use the funds to expedite prototype development of its sample preparation technology and computational approach.
Circulomics, Bionano, Sage Science, RevoluGen, and others have been developing methods for extracting DNA hundreds of kilobases and up to megabases in length.
The firms originally inked the agreement in 2015 and have now extended it until 2025.
The company plans to use the funding to further develop its Xdrop technology, which allows users to partition millions of single molecules in droplets.
CEO Brad Gray told investors at the JP Morgan Healthcare Conference that he believes the firm's GeoMx has advantages over competitors in the new market.
The round was led by Meritech Capital, with participation from Fidelity and Wells Fargo, and brings the company's total financing to date to $243 million.
Paragon and MGI Tech — a unit of BGI — have signed a distribution deal for certain of their respective next-generation sequencing panels and sample prep products.
Aside from its core synthetic biology business, the company has expanded into NGS and is looking to move into drug discovery and DNA data storage.
Twist, which went public in October, reported that its revenues doubled this year due to increased sales of its synthetic DNA products and the introduction of NGS products.
The company no longer plans to develop cell-free DNA assays for oncology but will instead look to commercialize a new target capture technology.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.